Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
American Journal of Hematology|April 1, 2018
Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective studyYael C Cohen, Avi Saranga, Moshe E Gatt, et al.
British Journal of Haematology|April 30, 2015
Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trialAndre Goy, Sevgi Kalayoglu Besisik, Johannes Drach, et al.
Haematologica|August 13, 2013
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraTamar Tadmor, Alessia Bari, Stefano Sacchi, et al.
Cancer Immunology Research|October 3, 2020
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual SpecificityAnat Globerson Levin, Moran Rawet Slobodkin, Tova Waks, et al.
Blood|July 23, 2021
Peripheral B cells repress B-cell regeneration in aging through a TNF-α/IGFBP-1/IGF-1 immune-endocrine axisReem Dowery, David Benhamou, Eli Benchetrit, et al.
American Journal of Hematology|August 1, 2012
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-upTsila Zuckerman, Tamar Katz, Nuhad Haddad, et al.
International Journal of Laboratory Hematology|September 21, 2021
Evaluation of Scopio Labs X100 Full Field PBS: The first high-resolution full field viewing of peripheral blood specimens combined with artificial intelligence-based morphological analysisBen-Zion Katz, Michael D Feldman, Minychel Tessema, et al.
Annals of Hematology|January 1, 2017
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort studyYael C Cohen, Tsila Zuckerman, Moshe Yeshurun, et al.
British Journal of Haematology|November 17, 2015
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational studyEli Muchtar, Moshe E Gatt, Ory Rouvio, et al.
Molecular Cancer Research : MCR|August 15, 2019
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib TherapyOfrat Beyar-Katz, Ksenia Magidey, Anat Reiner-Benaim, et al.
Pageof 20